These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 15364130

  • 1. Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer.
    Yang J, Tan D, Asch HL, Swede H, Bepler G, Geradts J, Moysich KB.
    Lung Cancer; 2004 Oct; 46(1):29-42. PubMed ID: 15364130
    [Abstract] [Full Text] [Related]

  • 2. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

  • 3. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 4. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
    Dosaka-Akita H, Hommura F, Fujita H, Kinoshita I, Nishi M, Morikawa T, Katoh H, Kawakami Y, Kuzumaki N.
    Cancer Res; 1998 Jan 15; 58(2):322-7. PubMed ID: 9443412
    [Abstract] [Full Text] [Related]

  • 5. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
    Cancer; 2007 Jul 01; 110(1):215-23. PubMed ID: 17508409
    [Abstract] [Full Text] [Related]

  • 6. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma.
    Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Monden M, Yamamoto S, Iuchi K, Aozasa K.
    Ann Surg Oncol; 2004 Jul 01; 11(7):697-704. PubMed ID: 15231524
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 01; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
    Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR.
    J Clin Oncol; 2004 Nov 15; 22(22):4575-83. PubMed ID: 15542809
    [Abstract] [Full Text] [Related]

  • 9. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K.
    Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757
    [Abstract] [Full Text] [Related]

  • 10. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.
    Cancer; 2009 Apr 01; 115(7):1507-17. PubMed ID: 19170237
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Saintigny P, Besse B, Callard P, Vergnaud AC, Czernichow S, Colombat M, Girard P, Validire P, Breau JL, Bernaudin JF, Soria JC.
    Clin Cancer Res; 2007 Aug 15; 13(16):4825-31. PubMed ID: 17699861
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
    Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y, Ogawa J.
    Clin Cancer Res; 2005 Jul 15; 11(14):5084-9. PubMed ID: 16033821
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, Morioka Y, Takahashi C, Noda M, Ito H, Wada H, Tanaka F.
    Ann Surg Oncol; 2005 Oct 15; 12(10):817-24. PubMed ID: 16132376
    [Abstract] [Full Text] [Related]

  • 16. A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.
    Iwata T, Uramoto H, Sugio K, Fujino Y, Oyama T, Nakata S, Ono K, Morita M, Yasumoto K.
    Lung Cancer; 2005 Oct 15; 50(1):67-73. PubMed ID: 15950316
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 15; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 18. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
    Ruffato A, Mattioli S, Pileri S, Daddi N, D'Ovidio F, Pilotti V, Tazzari P.
    Eur J Cardiothorac Surg; 2009 Mar 15; 35(3):463-8. PubMed ID: 19150243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.
    Howard BA, Zheng Z, Campa MJ, Wang MZ, Sharma A, Haura E, Herndon JE, Fitzgerald MC, Bepler G, Patz EF.
    Lung Cancer; 2004 Dec 15; 46(3):313-23. PubMed ID: 15541816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.